Institutional investors hold a majority ownership of PCRX through the 109.53% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Pharmaceuticals: Other industry. Last, during the quarter ended September 2016, these large investors purchased a net $1.4 million shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
PARTNER FUND MANAGEMENT LP Bought 1.2 Million shares of Pacira Pharmaceuticals In...